Dosage and administration
Apply evenly and liberally on to lips.
Apply evenly and liberally on to lips.
DRUG FACTS
Octinoxate 7.0%, Octisalate 4.0%, Oxybenzone 3.5%.
Sunscreen.
Helps prevent sunburn. Higher SPF gives more sunburn protection.
Apply evenly and liberally on to lips.
Ricinus Communis (Castor) Seed Oil, Petrolatum, Beeswax, Euphorbia Cerifera (Candelilla) Wax, Cetearyl Alcohol, Tribehenin, Simmondsia Chinensis (Jojoba) Seed Oil, Butyrospermum Parkii (Shea Butter), Tocopheryl Acetate, Stevioside.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 65643-333-20 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d5ed-621f-e053-dbdaa90a74ad | BELLAGIO ® LIP MOISTURIZER SPF 15 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE, D- | INACTIVE INGREDIENT | A7E6112E4N | 1 | |
| Candelilla Wax | INACTIVE INGREDIENT | WL0328HX19 | 1 | |
| Castor Oil | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| Jojoba Oil | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| Shea Butter | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| Tribehenin | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| Yellow Wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65643-333 | 65643-333-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Octinoxate | 4Y5P7MUD51 | ACTIB |
| Octisalate | 4X49Y0596W | ACTIB |
| Oxybenzone | 95OOS7VE0Y | ACTIB |
| Castor Oil | D5340Y2I9G | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
| Yellow Wax | 2ZA36H0S2V | IACT |
| Candelilla Wax | WL0328HX19 | IACT |
| Cetostearyl Alcohol | 2DMT128M1S | IACT |
| Tribehenin | 8OC9U7TQZ0 | IACT |
| Jojoba Oil | 724GKU717M | IACT |
| Shea Butter | K49155WL9Y | IACT |
| .ALPHA.-TOCOPHEROL ACETATE, D- | A7E6112E4N | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET / ORAL | 3.22 mg | ||
| Candelilla Wax | CANDELILLA WAX | WL0328HX19 | TABLET / ORAL | 4 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, COATED / ORAL | 213.7 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| Candelilla Wax | CANDELILLA WAX | WL0328HX19 | TABLET, DELAYED RELEASE / ORAL | 1 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, DELAYED RELEASE / ORAL | 0.1 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| Candelilla Wax | CANDELILLA WAX | WL0328HX19 | TABLET, EXTENDED RELEASE / ORAL | 3 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, SUGAR COATED / ORAL | NA | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CAPSULE, EXTENDED RELEASE / ORAL | 80.67 mg | ||
| Candelilla Wax | CANDELILLA WAX | WL0328HX19 | TABLET, FILM COATED / ORAL | 0.8 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CAPSULE / ORAL | 44 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CREAM / TOPICAL | 5 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Shea Butter | SHEA BUTTER | K49155WL9Y | LOTION / TOPICAL | 2340 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a157f263-e955-493b-a5ea-1bd78cc82e04 | fb4d48b6-ee6f-41ec-9136-69d53455e270 | 2010-09-13 | a157f263-e955-493b-a5ea-1bd78cc82e04 fb4d48b6-ee6f-41ec-9136-69d53455e270 |
Adverse event summaries are temporarily unavailable. Other product information remains available.